RaySearch signs agreement with Shinva for large order in China
RaySearch Laboratories AB (publ) is pleased to announce an agreement with the Chinese radiation therapy machine manufacturer Shinva. Shinva has placed an order for 15 RayPlan®* systems which they will sell to customers in China.
RaySearch has over a number of years been delivering RayStation to Shinva, which Shinva has sold together with their linear accelerators in China. The new order of 15 RayPlan systems that Shinva now has purchased will be sold in the same way.
Gery Zhao, General Manager, Shinva, says: “I am delighted about our cooperation with RaySearch and am confident that this partnership will pave the way for success in the Chinese market. At Shinva, we are committed to taking advantage of the new market opportunities in the upcoming year.”
Johan Löf, founder and CEO, RaySearch, says: “This order from Shinva is indicative of the strong position that Shinva has in the Chinese market. We appreciate the partnership with Shinva and that they, and their customers in China, choose RayPlan as their treatment planning system. The Chinese market has great potential for the future, and we look forward to a continued strong collaboration with Shinva.”
The order value is approximately MSEK 10.5, excluding service contract.
For more information, please contact:
Johan Löf, founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0) 8 510 530 00
johan.lof@raysearchlabs.com
About Shinva
Shinva Medical Instrument CO., LTD is one of the leading medical technology enterprises in China. It is the chairman unit of China Association for Medical Devices Industry and the first domestic medical technology enterprise that owns a state level enterprise technical center. Shinva has product lines within the areas of infection control, radiation and diagnosis equipment, operation room equipment, dental products, medical waste treatment and laboratory equipment. The company has been listed on the Shanghai stock exchange since 2002.
About RaySearch
RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation®* treatment planning system (TPS) and the oncology information system (OIS) RayCare®*. The most recent additions to the RaySearch product line are RayIntelligence® and RayCommand®*. RayIntelligence is an oncology analytics system (OAS) which enables cancer clinics to collect, structure and analyze data. RayCommand, a treatment control system (TCS), is designed to link the treatment machine and the treatment planning and oncology information systems.
RaySearch's software has been sold to over 900 clinics in more than 40 countries. The company was founded in 2000 as a spin-off from the Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since 2003. More information is available at raysearchlabs.com.
About RayStation and RayPlan
RayStation®* is a flexible, innovative treatment planning system, chosen by many leading cancer centers worldwide. It combines unique features such as unmatched adaptive therapy capabilities, multi-criteria optimization, market-leading algorithms for treatment plan optimization for HDR brachytherapy and external beam therapy with photons, electrons, and protons, as well as helium and carbon ions. RayStation supports a wide range of treatment machines, providing one control center for all treatment planning needs and ensuring centers get greater value from existing equipment. RayStation also seamlessly integrates with RayCare®*. By harmonizing the treatment planning, the care of cancer patients worldwide is improved.
The RayPlan®* treatment planning system makes the innovative RayStation®* technology accessible to clinics that need a cost-effective and streamlined solution. Fast, efficient and straightforward to use, RayPlan supports the full range of treatment planning activities for 3D-CRT, IMRT, VMAT, TomoTherapy and electron beam radiation therapy.
* Subject to regulatory clearance in some markets.
Tags:
